These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1310902)

  • 1. Cholera toxin promotes the proliferation of anti-mu antibody-prestimulated human B cells.
    Anastassiou ED; Yamada H; Boumpas DT; Tsokos GC; Thyphronitis G; Balow J; Mond JJ
    Cell Immunol; 1992 Mar; 140(1):237-47. PubMed ID: 1310902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation.
    Anastassiou ED; Yamada H; Francis ML; Mond JJ; Tsokos GC
    J Immunol; 1990 Oct; 145(8):2375-80. PubMed ID: 2120330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
    Lycke NY
    J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation.
    Francis ML; Okazaki I; Moss J; Kurosky A; Pecanha LM; Mond JJ
    J Immunol; 1995 May; 154(10):4956-64. PubMed ID: 7730606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bacterial toxins on human B cell activation. II. Mitogenic activity of the B subunit of cholera toxin.
    Dugas B; Paul-Eugène N; Génot E; Mencia-Huerta JM; Braquet P; Kolb JP
    Eur J Immunol; 1991 Feb; 21(2):495-500. PubMed ID: 1847876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation.
    Francis ML; Moss J; Fitz TA; Mond JJ
    J Immunol; 1990 Nov; 145(10):3162-9. PubMed ID: 2172379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.
    Francis ML; Ryan J; Jobling MG; Holmes RK; Moss J; Mond JJ
    J Immunol; 1992 Apr; 148(7):1999-2005. PubMed ID: 1312102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
    Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
    Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    Anderson DL; Tsoukas CD
    J Immunol; 1989 Dec; 143(11):3647-52. PubMed ID: 2555413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis.
    Roper RL; Phipps RP
    J Immunol; 1992 Nov; 149(9):2984-91. PubMed ID: 1328389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonistic and antagonistic effects of cholera toxin on human B lymphocyte proliferation.
    Garrone P; Banchereau J
    Mol Immunol; 1993 May; 30(7):627-35. PubMed ID: 8387635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin.
    Woogen SD; Ealding W; Elson CO
    J Immunol; 1987 Dec; 139(11):3764-70. PubMed ID: 2824614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
    Gouy H; Cefai D; Christensen SB; Debre P; Bismuth G
    J Immunol; 1991 Aug; 147(3):757-66. PubMed ID: 1650386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling events associated with the induction of proliferation of normal human B lymphocytes by two different antigenically related human B cell growth factors (high molecular weight B cell growth factor (HMW-BCGF) and the complement factor Bb).
    Ambrus JL; Chesky L; Chused T; Young KR; McFarland P; August A; Brown EJ
    J Biol Chem; 1991 Feb; 266(6):3702-8. PubMed ID: 1847385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD; Turo K; Dieleman LA; Beagley KW; Elson CO
    J Immunol; 1993 Apr; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP.
    Vazquez A; Auffredou MT; Galanaud P; Leca G
    J Immunol; 1991 Jun; 146(12):4222-7. PubMed ID: 1645759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective effects of cholera toxin on the activation of mouse B cells by different polyclonal activators.
    Klaus GG; Vondy K; Holman M
    Eur J Immunol; 1987 Dec; 17(12):1787-92. PubMed ID: 2826173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.